Little House Capital LLC acquired a new position in shares of Colgate-Palmolive (NYSE:CL) during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm acquired 13,582 shares of the company’s stock, valued at approximately $998,000.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Nuveen Asset Management LLC boosted its position in Colgate-Palmolive by 16,117.1% during the 2nd quarter. Nuveen Asset Management LLC now owns 6,435,107 shares of the company’s stock valued at $461,204,000 after acquiring an additional 6,395,426 shares in the last quarter. Invesco Ltd. boosted its position in Colgate-Palmolive by 201.8% during the 2nd quarter. Invesco Ltd. now owns 8,642,044 shares of the company’s stock valued at $619,374,000 after acquiring an additional 5,778,145 shares in the last quarter. AQR Capital Management LLC boosted its position in Colgate-Palmolive by 52.2% during the 2nd quarter. AQR Capital Management LLC now owns 3,485,442 shares of the company’s stock valued at $249,801,000 after acquiring an additional 1,195,074 shares in the last quarter. Vanguard Group Inc. boosted its position in Colgate-Palmolive by 1.4% during the 2nd quarter. Vanguard Group Inc. now owns 76,502,840 shares of the company’s stock valued at $5,482,958,000 after acquiring an additional 1,056,530 shares in the last quarter. Finally, Natixis boosted its position in Colgate-Palmolive by 504.3% during the 2nd quarter. Natixis now owns 1,009,727 shares of the company’s stock valued at $72,367,000 after acquiring an additional 842,644 shares in the last quarter. Institutional investors own 76.09% of the company’s stock.
Several analysts have issued reports on CL shares. Citigroup increased their target price on Colgate-Palmolive from $77.00 to $79.00 and gave the company a “neutral” rating in a research report on Tuesday, August 20th. JPMorgan Chase & Co. dropped their target price on Colgate-Palmolive from $76.00 to $71.00 and set a “neutral” rating on the stock in a research report on Monday, November 4th. Piper Jaffray Companies began coverage on Colgate-Palmolive in a research report on Tuesday, August 13th. They set an “overweight” rating on the stock. Berenberg Bank began coverage on Colgate-Palmolive in a research report on Wednesday, October 16th. They issued a “sell” rating and a $58.00 price objective for the company. Finally, UBS Group lowered their price objective on Colgate-Palmolive from $82.00 to $80.00 and set a “buy” rating for the company in a research report on Tuesday, November 5th. Four investment analysts have rated the stock with a sell rating, eight have given a hold rating and six have assigned a buy rating to the stock. Colgate-Palmolive currently has a consensus rating of “Hold” and an average target price of $72.57.
In other Colgate-Palmolive news, Chairman Ian M. Cook sold 19,500 shares of Colgate-Palmolive stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $73.05, for a total transaction of $1,424,475.00. Following the completion of the transaction, the chairman now owns 1,030,575 shares in the company, valued at approximately $75,283,503.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Chairman Ian M. Cook sold 17,750 shares of Colgate-Palmolive stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $68.30, for a total value of $1,212,325.00. Following the transaction, the chairman now owns 995,075 shares of the company’s stock, valued at approximately $67,963,622.50. The disclosure for this sale can be found here. Insiders sold a total of 172,477 shares of company stock valued at $12,238,718 in the last 90 days. 1.14% of the stock is currently owned by company insiders.
CL stock traded down $0.09 during midday trading on Monday, reaching $66.54. The stock had a trading volume of 2,624,073 shares, compared to its average volume of 3,535,509. The stock has a market cap of $57.34 billion, a PE ratio of 22.40, a P/E/G ratio of 5.24 and a beta of 0.73. The company has a debt-to-equity ratio of 43.94, a quick ratio of 0.25 and a current ratio of 1.03. The firm has a fifty day simple moving average of $69.58 and a two-hundred day simple moving average of $71.58. Colgate-Palmolive has a 52-week low of $57.51 and a 52-week high of $76.41.
Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, November 1st. The company reported $0.71 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.70 by $0.01. The company had revenue of $3.93 billion during the quarter, compared to analyst estimates of $3.95 billion. Colgate-Palmolive had a return on equity of 6,492.71% and a net margin of 15.04%. The firm’s quarterly revenue was up 2.2% on a year-over-year basis. During the same quarter last year, the business posted $0.72 EPS. On average, sell-side analysts predict that Colgate-Palmolive will post 2.83 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Wednesday, October 23rd will be paid a $0.43 dividend. The ex-dividend date of this dividend is Tuesday, October 22nd. This represents a $1.72 dividend on an annualized basis and a yield of 2.58%. Colgate-Palmolive’s dividend payout ratio (DPR) is 57.91%.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
Featured Story: Monthly Dividend Stocks Can Provide Solid Income
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.